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Abstract Basigin (Bsg) is a transmembrane glycoprotein
belonging to the immunoglobulin superfamily. Bsg knock-out
mice exhibit infertility of both sexes. Based on limited results,
defective implantation has been considered to be the cause of the
female infertility. We demonstrate here that disruption of the Bsg
gene produces the failure of female reproductive processes
including not only implantation but also fertilization. Bsg mRNA
expression in cumulus cells and basolateral localization of the
Bsg protein in the endometrial epithelium further support the
importance of Bsg in these processes.
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1. Introduction
Basigin (Bsg) is a transmembrane glycoprotein belonging to
the immunoglobulin (Ig) superfamily with two Ig domains in
its extracellular portion [1,2]. Chicken Bsg (HT7/neurothelin/
5A11) has been implicated in construction of the blood-brain
barrier, as it is speci¢cally expressed in capillary endothelial
cells in the brain [3^6]. It has also been implicated in the
neuronal-glial interaction in the retina during development
[7,8]. Human Bsg (M6/EMMPRIN) has been implicated in
the activation of lymphocytes and the induction of matrix
metalloproteases [9,10].
We generated Bsg knock-out mice. Bsg null mutants exhibit
normal functions of the blood-brain barrier [11]. However,
they show unexpected phenotypes, as follows. Many Bsg
null mutant embryos are lost around the time of implantation
[12]. Adult null mutants exhibit lowered sensitivity to irritat-
ing odors [11], and de¢cits in spatial learning and memory
[13]. Moreover, both surviving male and female Bsg null mu-
tants are infertile [12]. In the case of males, spermatogenesis is
arrested at the prophase of the ¢rst meiosis, consequently the
adult mice exhibit azoospermia [12]. In contrast to the clear
cause of male infertility, the cause of female sterility has been
obscure. In a previous study, it was suggested that the pri-
mary cause of female sterility may be the failure of implanta-
tion because most blastocysts transferred to the uteri of null
mutants were lost in early pregnancy and Bsg mRNA expres-
sion was regionally elevated at the site of embryo apposition
in the uterine endometrium [12]. In the present study, to verify
the roles of Bsg in pregnancy and to determine the cause of
their infertility, we have extended the previous studies by sys-
tematically examining female null mutants.
2. Materials and methods
2.1. In vitro fertilization
Pregnant mare serum (5 IU) dissolved in saline was injected intra-
peritoneally into each female mouse at 16.00 h. Forty-eight hours
later, 5 IU of human chorionic gonadotropin (hCG) was injected in
the same way. At 14 h after injection of the hCG into the female mice,
male mice were killed by cervical dislocation. Their epididymides were
resected and punctured with a needle. A white drop of the sperm was
introduced into a drop of Whittingham’s medium containing 30 mg/
ml of bovine serum albumin (BSA) covered by mineral oil, followed
by incubation for 1 h at 37‡C under 5% CO2-95% air. At 16 h after
the injection of hCG, the female mice were killed and their oviducts
were resected. Oocytes covered with follicular cells were introduced
into a drop of Whittingham’s medium containing 30 mg/ml of BSA
equilibrated under the same conditions as for sperm. Whittingham’s
medium containing sperm was added to a drop containing oocytes to
give a ¢nal concentration of 200 sperm/Wl. After 6 h incubation, the
oocytes were transferred to M16 medium containing 4 mg/ml of BSA.
The oocytes were incubated overnight and those exhibiting cell divi-
sion were regarded as being fertilized.
2.2. Histological analyses
Mice were anesthetized with Nembutal, and then perfused with 10
ml of saline followed by 50 ml of 4% paraformaldehyde in phosphate-
bu¡ered saline (PBS). The tissues were removed and ¢xed in 4%
paraformaldehyde in PBS at 4‡C overnight. After embedding in par-
a⁄n, sections of 5 Wm thickness were cut and placed on silane-coated
slide glasses, and then subjected to staining or in situ hybridization.
Generation of anti-Bsg antibodies was performed as described pre-
viously [14]. For immunohistochemistry, a uterus was ¢xed with 3%
paraformaldehyde in 0.1 M phosphate bu¡er (pH 7.4), followed by
serial washing with 10, 15 and 20% sucrose in phosphate bu¡er. The
specimen was embedded in OCT compound, and then frozen sections
were cut and placed on lysine-coated slide glasses. The sections were
incubated in Tris-HCl bu¡er (pH 7.4) containing anti-Bsg antibodies
(dilution 1:50) overnight at 4‡C. After thorough washing with PBS,
the sections were processed with FITC-labeled anti-mouse IgG for 1 h
at room temperature. The sections were washed with PBS and then
examined under a £uorescence microscope.
In situ hybridization for Bsg expression was performed as described
previously [14].
2.3. Northern blot analysis
Northern blot analysis was performed as described previously [15].
Brie£y, total RNA was extracted from freshly removed tissues by the
method described previously [16]. 10 Wg of each RNA was separated
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in a 1% agarose gel, followed by transfer to a nylon membrane. A 32P-
labeled probe generated from a cDNA fragment covering the open
reading frame of mouse Bsg [1] was hybridized to the membrane. The
membrane was washed at room temperature three times in 0.1% SDS,
2USCC, and then at 55‡C twice in 0.1% SDS, 0.1USCC. Autoradiog-
raphy was performed with a luminographic analyzer (BAS 2000, Fuji
Photo¢lm).
3. Results
3.1. Female Bsg knock-out mice are infertile, but appear to
be normal in ovulation, sex cycle and coital behavior
We examined 16 female mice homozygous for the Bsg gene
mutation, which had been mated with wild-type male mice,
for more than 3 months. Although vaginal plugs were occa-
sionally observed, there was no progeny. The frequency of
vaginal plugs in null mutants was comparable to that in
wild-type mice (data not shown), indicating that coital behav-
ior was not a¡ected in the null mutants although they exhib-
ited a de¢cit in spatial memory [13]. The sex cycle, evaluated
by means of vaginal smears, was normal (data not shown).
Furthermore, the ovaries of Bsg null mutants contained ma-
ture follicles and corpora lutea, and superovulation with preg-
nant mare serum and hCG, which was performed for the null
mutants, resulted in successful induction of ovulation [12].
3.2. In vitro and in vivo fertilization
Oocytes obtained by means of superovulation were em-
ployed for in vitro fertilization. Null mutant oocytes exhibited
a signi¢cantly reduced ability of fertilization: successful fertil-
ization was observed in 69/99 (69.7%) of the oocytes from the
null mutants and 72/78 (92.3%) of those from the wild-type;
P = 0.0002 (Table 1). We then examined in vivo fertilization.
At 3.5 days p.c. after mating with wild-type male mice, eggs
were collected to determine whether or not they had devel-
oped into ones with more than two blastomeres. Only one of
39 eggs collected from the null mutants had developed nor-
mally, the others remaining unfertilized, many of which ap-
peared degenerated (Table 2). In contrast, 14 of 26 eggs from
the wild-type mice had developed normally. The di¡erence
was also statistically signi¢cant (P6 0.0001). The in vivo fer-
tilization results appeared more severely a¡ected than the in
vitro ones, probably due to the more rigorous in vivo condi-
tions.
3.3. The genital tract and reach of sperm
The fertilization failure prompted us to examine the intact-
ness of the genital tract. The genital tract, including the vagi-
na, uterus and oviduct, was histologically normal [12]. When a
solution of bromophenol blue was injected into the oviduct
from the open end at the ¢mbria, the dye was detected in the
uterine lumen (data not shown), indicating that there was no
obstruction of the oviduct. This was further con¢rmed by the
fact that oocytes were successfully collected at 2.5 days p.c. by
means of oviduct £ushing. After mating with wild-type male
mice, many sperm were observed in the oviducts of the null
mutants: the number and movement of sperm were compara-
ble to those in the oviducts of the wild-type mice (data not
shown).
3.4. Bsg expression in the ovary
One possible explanation for the fertilization failure is in-
complete oocyte maturation. To examine this possibility, we
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Table 1
In vitro fertilization
Zygocity Numbers of Rate of fertilization (%)
Oocytes Sperm Females Oocytes Fertilized eggs
Null mutant Wild-type 4 99 69* 69.7
Wild-type Wild-type 2 78 72* 92.3
*P = 0.0002.
Fig. 1. Bsg mRNA expression in the ovary. In situ hybridization for Bsg mRNA was performed using an ovary from a wild-type mouse. Gran-
ulosa cells including cumulus cells (arrow) strongly expressed Bsg mRNA, but mesenchymal cells and the corpora lutea (data not shown)
scarcely expressed it. A: Hematoxylin and eosin staining. B: Antisense probe of Bsg. C: Sense probe. Bar, 100 Wm.
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performed in situ hybridization for Bsg mRNA expression in
the ovary of wild-type mice. Bsg mRNA was restrictedly ex-
pressed in granulosa cells including cumulus cells (Fig. 1),
whereas other regions, including the corpora lutea (data not
shown) and mesenchyme (Fig. 1), scarcely expressed Bsg
mRNA.
3.5. Bsg expression in the uterus
We recently demonstrated that the transfer of normal blas-
tocysts into null mutant uteri resulted in the loss of most
embryos during early pregnancy: upon the transfer of a total
of 86 wild-type blastocysts into the uteri of six Bsg-null mu-
tant females, only four embryos survived later than the time
of implantation, whereas the transfer of 90 blastocysts into
wild-type females resulted in 41 embryos being obtained [12].
These data strongly suggest that failure of implantation is one
of the prominent causes of female sterility in Bsg null mu-
tants. This led us to further examine Bsg expression in the
uterus during early pregnancy.
On Northern blot analysis, Bsg mRNA expression was ob-
served to increase transiently during early pregnancy with
peak at around 4.5 days p.c., when implantation takes place
(Fig. 2). As we had observed stronger expression of Bsg at the
sites of embryo apposition in the endometrium than other
sites in coronal sections [12], in situ hybridization for Bsg
was further performed on longitudinal sections of uteri
around the time of implantation. Bsg expression in the endo-
metrium was again much stronger at sites with embryos in the
lumen than at other sites without embryos (data not shown).
Furthermore, on £uorescence immunohistochemistry, the Bsg
protein was found to be localized in the endometrial epithe-
lium, mostly on the basolateral surface (Fig. 3).
4. Discussion
In this paper, we have demonstrated multiple failures in
female reproductive processes, that include fertilization and
implantation, in Bsg knock-out mice. Multiple female repro-
ductive failures were recently reported for cyclooxygenase 2
knock-out mice, in which ovulation, fertilization, implanta-
tion and deciduation are a¡ected [17]. Cyclooxygenase 2 is
the rate-limiting enzyme in the biosynthesis of prostaglandins
and is associated with the nuclear envelope. Thus, to the best
of our knowledge, Bsg is the ¢rst reported membrane protein
of which a defect leads to multiple female reproductive fail-
ures. Since the sex cycle and ovulation are not a¡ected in Bsg
null mutants, it is not likely that the failures are due to indi-
rect e¡ects via hormonal failure or defective responsiveness to
hormones. Rather than that, Bsg expression in cumulus cells
and the endometrial epithelium suggests that Bsg expressed in
these regions plays direct roles in oocyte maturation and im-
plantation, respectively.
Since Bsg is expressed in cumulus cells, and interaction
between oocyte and cumulus cells is considered important
for the production of eggs competent as to fertilization [18],
the absence of Bsg in cumulus cells is most likely the cause of
fertilization failure in Bsg knock-out mice. In addition, it is of
note that cyclooxygenase 2 is expressed in cumulus cells as
well as at the site of blastocyst implantation in the uterus [17],
this being quite reminiscent of the Bsg expression pro¢le. Cy-
clooxygenase 2 has also been implicated in tumor invasion
[19], and Bsg expressed in tumor cells induces matrix metal-
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Fig. 2. Northern blot analysis of Bsg expression during early preg-
nancy. Bsg expression in the uterus was stronger at 2.5 and 4.5
days p.c., and then decreased to 10.5 days p.c. Bsg was strongly ex-
pressed in the embryo at 10.5 days p.c. The lower panel shows ethi-
dium bromide staining, which indicates that comparable amounts
were loaded on the lanes.
Fig. 3. Bsg protein localization in the uterus. Bsg expression in the
uterus at 4.25 days p.c. was observed by immuno£uorescence micro-
scopy with anti-Bsg antibodies. Ee, endometrial epithelium. L, ute-
rine lumen. Bar, 25 Wm.
Table 2
In vivo fertilization
Zygocity Numbers of Rate of fertilization (%)
Oocytes Sperm Females Oocytes Fertilized eggs
Null mutant Wild-type 8 39 1* 2.6
Wild-type Wild-type 4 26 14* 53.8
*P6 0.0001.
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loproteases in surrounding mesenchymal cells [9]. It remains
to be determined whether or not there is any relation between
cyclooxygenase 2 and Bsg expression as well as their func-
tional relation.
Many gene targeting studies, including on the genes for
cyclooxygenase 2, Hoxa-10, leukemia inhibitory factor
(LIF), L1 integrin, EGF receptor, vav, even-skipped, FGF4
and Fug1, have revealed embryonic lethality at the time of
implantation or in the early post-implantation period [17,20^
31]. However, in most cases, embryonic death was attributed
to the loss of the functions of targeted genes in the embryos,
but not in the uteri, because expression of the genes was
detected in wild-type embryos, and null mutant embryos
died in the uteri of heterozygotes. However, in the cases of
cyclooxygenase 2, Hoxa-10, and LIF knock-out mice, normal
blastocysts cannot become implanted in the uteri of null mu-
tants [17,22^24]. In wild-type mice, LIF is expressed in the
uterine endometrial glands speci¢cally on the fourth day of
pregnancy [32]. LIF secreted around the time of implantation
probably acts on either the blastocysts or the uterus, and thus
plays a critical role in implantation. In the cases of Bsg and
cyclooxygenase 2, strong expression is detected in the uterine
wall at the site of embryo apposition [12,17]. In addition, the
expression pro¢le of HB-EGF in the uterus is very reminiscent
of those of Bsg and cyclooxygenase 2 [33]. Although elucida-
tion of the biological signi¢cance of HB-EGF expression in
the uteri awaits a knock-out study on the gene, multiple mol-
ecules are now available for investigation of the mechanism of
implantation.
It should be noted that the Bsg protein has two important
characteristics concerning implantation. First, the extracellu-
lar domain of Bsg contains two Ig-like domains. Since many
members of the Ig superfamily serve as adhesion molecules,
Bsg in the endometrial epithelium could promote the attach-
ment of a blastocyst to the uterus. Second, it has been re-
ported that human Bsg (EMMPRIN) is expressed in human
cancer cells, and also induces matrix metalloproteases expres-
sion in mesenchymal cells when they encounter cancer cells
[9]. Thus, another possible in vivo function of Bsg in implan-
tation is that Bsg in the endometrial epithelium facilitates the
production of matrix metalloproteases by trophoblasts, and
thereby promotes the invasion of trophoblasts into the uterine
wall. The basolateral localization of the Bsg protein in endo-
metrial epithelial cells may indicate the latter possibility is
more likely, although the precise mechanism remains to be
elucidated.
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